期刊
EUROPEAN UROLOGY
卷 71, 期 1, 页码 8-12出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.eururo.2016.06.025
关键词
bladder cancer; bladder cancer stem cells; genetic alteration; self-renewal; single-cell sequencing; tumor evolution
资金
- National Natural Science Foundation of China [81330047, 81301740, 81472413]
- 973 Program [2015CB755500, 2014CB745200]
- Innovation Program of Shenzhen [JCYJ20130401114715714, CXZZ20140826163906370, JCYJ20130401114928183, JSGG20130411091246833, CXZZ2013051653248144, 20120612131638712]
Cancer stem cells are considered responsible for many important aspects of tumors such as their self-renewal, tumor-initiating, drug-resistance and metastasis. However, the genetic basis and origination of human bladder cancer stem cells (BCSCs) remains unknown. Here, we conducted single-cell sequencing on 59 cells including BCSCs, bladder cancer non-stem cells (BCNSCs), bladder epithelial stem cells (BESCs) and bladder epithelial non-stem cells (BENSCs) from three bladder cancer (BC) specimens. Specifically, BCSCs demonstrate clonal homogeneity and suggest their origin from BESCs or BCNSCs through phylogenetic analysis. Moreover, 21 key altered genes were identified in BCSCs including six genes not previously described in BC (ETS1, GPRC5A, MKL1, PAWR, PITX2 and RGS9BP). Co-mutations of ARID1A, GPRC5A and MLL2 introduced by CRISPR/Cas9 significantly enhance the capabilities of self-renewal and tumor-initiating of BCNSCs. To our knowledge, our study first provides an overview of the genetic basis of human BCSCs with single-cell sequencing and demonstrates the biclonal origin of human BCSCs via evolution analysis. Patient summary: Human bladder cancer stem cells show the high level of consistency and may derived from bladder epithelial stem cells or bladder cancer non-stem cells. Mutations of ARID1A, GPRC5A and MLL2 grant bladder cancer non-stem cells the capability of self-renewal. (C) 2016 European Association of Urology. Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据